- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (68)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (720)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (156)
- Colon Cancer (164)
- Colorectal Cancer (112)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (8)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (8)
- Kidney Cancer (126)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (286)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (172)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (236)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (96)
- Tonsil Cancer (30)
- Uterine Cancer (80)
- Vaginal Cancer (16)
- Vulvar Cancer (20)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (632)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (908)
- Research (396)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (606)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (322)
- Symptoms (184)
- Treatment (1784)
MD Anderson physician receives award for decades of accomplishments
2 minute read | Published December 05, 2012
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on December 05, 2012
Fifty years from now when an author is compiling a review of modern cancer therapy for a historical publication, he'll undoubtedly recognize the accomplishments of Gabriel Hortobagyi, M.D., a visionary cancer physician and researcher whose discoveries saved countless women from breast cancer.
He first became familiar with the disease walking the hallways of an Ohio hospital during his internal medicine residency. Hortobagyi was intrigued by the opportunity to help patients conquer a disease that posed more questions than answers. More than 40 years later, this pursuit still passionately consumes his career as a physician in MD Anderson's Department of Breast Medical Oncology and through collaborations around the world.
Today, at the 35th annual San Antonio Breast Cancer Symposium, Hortobagyi was presented with the William L. McGuire Memorial Lecture Award for his outstanding achievements.
"It's very humbling and gratifying to be selected by one's peers because everyone on the selection committee is a very accomplishment individual," Hortobagyi said. "It's very meaningful for me, and, of course, it's recognition of our group's accomplishments." Among his notable contributions was research that determined chemotherapy could reduce large breast tumors by up to 50 percent before surgery. In 1988, Hortobagyi published a 10-year study showing that a three-drug regimen administered before surgery showed promising results for patients with advanced disease. This approach was later applied with increased success to earlier stages of inoperable cancer.
Additionally, he's credited with establishing the role of bisphosphonates, a class of drugs used to treat osteoporosis, in the management of patients whose disease spread to their bones. With more than 600 articles published in scientific journals, his lifetime of service dedicated to the benefit of others speaks for itself.
Select the accompanying video to learn more about Hortobagyi's thoughts on receiving the McGuire Award and where he believes the field of breast cancer is headed in the future.